The von Hippel-Lindau tumor suppressor gene expression level has prognostic value in neuroblastoma
Open Access
- 8 May 2006
- journal article
- early detection-and-diagnosis
- Published by Wiley in International Journal of Cancer
- Vol. 119 (3), 624-629
- https://doi.org/10.1002/ijc.21888
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- High‐resolution detection and mapping of genomic DNA alterations in neuroblastomaGenes, Chromosomes and Cancer, 2005
- Neuroblastomas with chromosome 11q loss and single copy MYCN comprise a biologically distinct group of tumours with adverse prognosisBritish Journal of Cancer, 2001
- Comparative genomic hybridization (CGH) analysis of stage 4 neuroblastoma reveals high frequency of 11q deletion in tumors lackingMYCN amplificationInternational Journal of Cancer, 2001
- Multicentre analysis of patterns of DNA gains and losses in 204 neuroblastoma tumors: How many genetic subgroups are there?Medical and Pediatric Oncology, 2001
- Deletion of 11q23 is a frequent event in the evolution ofMYCN single-copy high-risk neuroblastomasMedical and Pediatric Oncology, 2000
- Genetic heterogeneity of neuroblastoma studied by comparative genomic hybridizationGenes, Chromosomes and Cancer, 1998
- Loss of heterozygosity of 3p markers in neuroblastoma tumours implicate a tumour-suppressor locus distal to the FHIT geneBritish Journal of Cancer, 1998
- von Hippel-Lindau DiseaseMedicine, 1997
- Representational difference analysis and loss of heterozygosity studies detect 3p deletions in neuroblastomaEuropean Journal Of Cancer, 1997
- VON HIPPEL-LINDAU TUMOUR SUPPRESSOR GENE. LOCALIZATION OF EXPRESSION BYIN SITU HYBRIDIZATIONThe Journal of Pathology, 1996